Zymo Research Corp., a global life sciences company developing molecular tools for research and translational applications, has joined the Blood Profiling Atlas in Cancer (BLOODPAC) Consortium, a ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

According to MarketsandMarkets™, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 ...

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...

According to MarketsandMarkets, the Epigenetics Market is projected to grow from about USD 2.22 billion in 2026 to USD 3.92 billion by 2031 ...

Accurate RNA splicing is essential for gene expression and human health, yet predicting how DNA sequence variations affect ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharma and diagnostics giant Roche on Monday ...

Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in ...

T cells offer several advantages for solid tumor immunotherapy, including innate tumor recognition, human leukocyte ...